We propose that the inhibition of furin as a therapeutic strategy not only has the potential to restore airways hydration and rescue MCC, but also may relieve the burden of infection and chronic inflammatory and remodelling processes associated with lung function decline in CF. The gene discussed is FURIN; the disease is infection.